Misleading Websites
Law of Social & Emerging Media | Social & Emerging Media Law Blog | Wa
AUGMENTED LEGALITY is a collection of thoughts and observations about the emerging technology of “augmented reality” (or “AR”) and its legal implications. Its author is Brian D. Wassom, a partner with the law firm of Honigman Miller Schwartz and Cohn LLP, based in Detroit, Michigan.
The Critical Thinker's Guide to News, Politics, Religion, and Business
Consumer information exposing scams and lies in corporate america, media, politics government
John Fare: The Story of Missing Parts
Have you ever heard of John Fare? Or John Charles Faré? Don’t be mislead - it is the same person.
The Tiny Print
TheTinyPrint.com delves into the world of fine print and disclaimers in advertising.
Verify Fraud™ | Official Website The trust you need for the internet
The Good The Bad & The Ugly Taking the trust of the internet to the limits™ Visit us soon at www.VerifyFraud.org as we build the website and give you an amazing new service. #VerifyFraud
India Telecom | Telecom Yellow Pages | SMS World | Bulk SMS | IVR | Fr
This site shows the progress of India in the field of telecommunications- Bulk SMS, API Software, SMS
Guff News - Your Resource for all fake, bs, hoax, clickbait, misleadin
GuffNews is a community-driven source for all websites on the internet that are bullshit, fake, biased, misleading, clickbait-driven, satirical, or just responsible for the decline of western civilisation!You can add a website by clicking on the SUBMIT link at the top, or view newly added websites by clicking on the NE
Competition Act Lawyer Canada 416-887-9702 / 905-631-3662
Competition Act Lawyer - legal application of the Competition Act (Canada's anti-trust law) to mergers, acquisitions, divestitures, business purchases and sales
Evidence Bypass - Evaluating evidence of claims and statements
Evidence Bypass: Testing reason, logic, premise, argument and conclusion.
Home | Bullshit Asymmetry
A blog seeking truth in the current climate of American media and politics.
Concerned Shareholder | Bristol-Myers Squibb proposed Celgene acquisit
A two-fold question for Bristol-Myers Squibb shareholders regarding the proposed Celgene acquisition